Joshua Manning, DPM
Foot & Ankle Surgery · Cambridge, MANPI 1811456270
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (43.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Kairos Surgical Inc at 44.4% of the total. Reporting peaked in 2022 at $1,967 and has fallen 81.8% since, to $358 in 2025.
Across 39 payments — averaging $140.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$2K
- Stryker$2K
- Smith+Nephew$522
- Bioventus LLC$136
- Medtronic$80
- Shockwave Medical, Inc$71
- plus $21 from 1 others
What the payments were for
- Travel & lodging$1,24323%
- Food & beverage$1,83333%
- Education$2,40044%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 4 | $2,432 |
| Stryker | 20 | $2,213 |
| Smith+Nephew | 9 | $522 |
| Bioventus LLC | 3 | $136 |
| Medtronic | 1 | $80 |
| Shockwave Medical, Inc | 1 | $71 |
| Integra Lifesciences Corporation | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INBONE$926
- PROstep$483
- PROPHECY$281
- Stravix$225
- GRAFIX PL$225
- AUGMENT INJECTABLE$161
- Grafix$125
- STRAVIX PL$125
- ORTHOLOC 2 LAPIFUSE$120
- N/A$120
- Exogen Ultrasound Bone Healing System$120
- PRIME SERIES$113
How this compares
$5,476 in reported general payments places this provider in the 80th percentile of 122 foot & ankle surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 41 | $971 |
| Doxycycline Hyclate | 32 | $424 |
| Ketoconazole | 15 | $320 |
| Cephalexin | 52 | $320 |
| Methylprednisolone | 20 | $189 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $151 |
| Diclofenac Sodium | 27 | $147 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Cambridge
- Harry SchneiderCambridge$174K
- Philip BasileCambridge$90K
- Jeremy CookCambridge$4K
- Emily CookCambridge$2K
- Jeffrey NgCambridge$2K
- Craig LareauSpringfield$115K
- David SipalaBrighton$94K
- Michael SgangaNatick$90K
- Joseph FleckNorth Chelmsford$35K
- Michael SkoniecznyPlymouth$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.